Swiss generic drugmaker Acino (ACIN.S) said it has accepted a takeover offer from Avista Capital Partners and Nordic Capital valuing the company at about 398 million Swiss francs ($439 million). The private equity companies will offer 115 Swiss francs per share representing a 33 percent premium to Tuesday’s closing share price of 86.50 francs, Acino said in a statement. The company’s board unanimously supports the tender offer.
Help employers find you! Check out all the jobs and post your resume.